Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Collagen membranes improve melanocyte growth for treating skin depigmentation.

Older adults often have dry skin and itching, with high blood pressure frequently linked to skin problems.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Most patients with alopecia areata in Syria are young adult males, often with patchy scalp hair loss.

Apremilast shows promise for several skin conditions but needs more research.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Detoxil effectively treats chronic skin conditions by improving liver detoxification and reducing symptoms.

Pediatric lichen is rare and diverse, and dermoscopy helps improve diagnosis and management in children.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Lower illness acceptance is linked to more body dysmorphic disorder symptoms in patients with body modifications.

A new microneedle treatment can effectively repigment skin in vitiligo.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Combining platelet-rich products, biomaterials, and bioactive substances may improve skin treatment, but more research is needed.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

Early and accurate identification of primary scarring alopecias is crucial to prevent permanent hair loss.

Type-2 immunity may influence skin diseases and could be targeted for treatment.